Boulder's Clovis pairs with Bristol-Myers on breast, ovarian, prostate cancer treatments

Boulder's Clovis pairs with Bristol-Myers on breast, ovarian, prostate cancer treatments


Bouler-based Clovis Oncology has partnered with Bristol-Myers Squibb to evaluate the combination of two of the companies' drugs on several types of tumors. Three mid- to late-stage studies will evaluate the efficacy of Bristol-Myers' Opdivo in tandem with Clovis' Rubraca.



from Biotech News